Unknown

Dataset Information

0

T-cell TGF-? signaling abrogation restricts medulloblastoma progression.


ABSTRACT: Cancer cell secretion of TGF-? is a potent mechanism for immune evasion. However, little is known about how central nervous system tumors guard against immune eradication. We sought to determine the impact of T-cell TGF-? signaling blockade on progression of medulloblastoma (MB), the most common pediatric brain tumor. Genetic abrogation of T-cell TGF-? signaling mitigated tumor progression in the smoothened A1 (SmoA1) transgenic MB mouse. T regulatory cells were nearly abolished and antitumor immunity was mediated by CD8 cytotoxic T lymphocytes. To define the CD8 T-cell subpopulation responsible, primed CD8 T cells were adoptively transferred into tumor-bearing immunocompromised SmoA1 recipients. This led to generation of CD8(+)/killer cell lectin-like receptor G1 high (KLRG1(hi))/IL-7R(lo) short-lived effector cells that expressed granzyme B at the tumor. These results identify a cellular immune mechanism whereby TGF-? signaling blockade licenses the T-cell repertoire to kill pediatric brain tumor cells.

SUBMITTER: Gate D 

PROVIDER: S-EPMC4143044 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

T-cell TGF-β signaling abrogation restricts medulloblastoma progression.

Gate David D   Danielpour Moise M   Rodriguez Javier J   Kim Gi-Bum GB   Levy Rachelle R   Bannykh Serguei S   Breunig Joshua J JJ   Kaech Susan M SM   Flavell Richard A RA   Town Terrence T  

Proceedings of the National Academy of Sciences of the United States of America 20140731 33


Cancer cell secretion of TGF-β is a potent mechanism for immune evasion. However, little is known about how central nervous system tumors guard against immune eradication. We sought to determine the impact of T-cell TGF-β signaling blockade on progression of medulloblastoma (MB), the most common pediatric brain tumor. Genetic abrogation of T-cell TGF-β signaling mitigated tumor progression in the smoothened A1 (SmoA1) transgenic MB mouse. T regulatory cells were nearly abolished and antitumor im  ...[more]

Similar Datasets

| S-SCDT-EMM-2018-09830 | biostudies-other
| S-EPMC2689133 | biostudies-literature
| S-EPMC7300285 | biostudies-literature
| S-EPMC2245859 | biostudies-literature
| S-EPMC7886799 | biostudies-literature
| S-EPMC3567148 | biostudies-literature
2012-12-06 | E-GEOD-42773 | biostudies-arrayexpress
| S-EPMC9234672 | biostudies-literature
2012-12-06 | GSE42773 | GEO
| S-EPMC4352303 | biostudies-literature